Anticorps Recombinant de lapin anti-ATF4

ATF4 Recombinant Antibody for WB, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA, ChIP-qPCR

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA, ChIP-qPCR

Conjugaison

Non conjugué

CloneNo.

230306B5

N° de cat : 81798-2-PBS

Synonymes

230306B5, cAMP-dependent transcription factor ATF-4, CREB2, Cyclic AMP-responsive element-binding protein 2, Tax-responsive enhancer element-binding protein 67



Informations sur le produit

81798-2-PBS cible ATF4 dans les applications de WB, IF/ICC, FC (Intra), Cytometric bead array, Indirect ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène ATF4 Protéine recombinante Ag1279
Nom complet activating transcription factor 4 (tax-responsive enhancer element B67)
Masse moléculaire calculée 39 kDa
Poids moléculaire observé45-50 kDa
Numéro d’acquisition GenBankBC022088
Symbole du gène ATF4
Identification du gène (NCBI) 468
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

ATF4 is a transcription factor, that accumulates predominantly in osteoblasts, where it regulates terminal osteoblast differentiation and bone formation. As a basic leucine-zipper (bZip) transcription factor, ATF4 can regulate amino acid metabolism, cellular redox state, and anti-stress responses. It also regulates age-related and diet-induced obesity and glucose homeostasis in mammals, and has conserved metabolic functions in flies. Due to its location at chromosome 22q13, a region linked to schizophrenia, ATF4 is considered as a positional candidate gene for schizophrenia. Otherwise, since ATF4 is induced by tumour microenvironmental factors, and regulates processes relevant to cancer progression, it might serve as a potential therapeutic target in cancer.

{{ptg:RelatedPrimaryAntibodies}}